HealthWatchlist verdict: Topical coconut oil has encouraging clinical evidence for supporting the fragile skin of premature babies under neonatal care. That does not make it a universal treatment for baby rashes or prove that it prevents serious infection. Follow the baby’s clinical team’s skin-care plan.
This is a moisturising oil, not aromatherapy
Coconut oil is a fatty oil, rather than a concentrated volatile essential oil. Its skin-care research concerns moisturising and supporting the skin barrier. It should not be grouped with lavender or tea tree drops when deciding what to put on a baby.
The most relevant neonatal research involves premature babies, whose skin barrier is less mature. Those infants have different care needs from healthy full-term newborns. A hospital study is not a home-treatment instruction for any baby with dry or red skin.
What the skin-barrier trials found
A randomised trial involving 74 very-low-birth-weight infants compared coconut oil application with standard care. Over the first week, the oil group lost less water through the skin and had better skin-condition scores. The study did not use massage as part of the oil intervention.
A trial of 72 babies born before 30 weeks compared routine care with added coconut oil over 21 days. Skin condition was maintained better in the coconut-oil group. However, common neonatal outcomes, including sepsis and mortality, did not differ between groups.
This second study was open-label, meaning caregivers knew which treatment was being given. Its size was also insufficient to settle uncommon but serious outcomes. The positive skin finding and the absence of a demonstrated sepsis benefit both belong in the conclusion.
A more recent 66-infant trial compared coconut oil, sunflower seed oil and a control group. It reported better skin scores and weight at one month after discharge in both oil groups. The small sample and relatively mature infants limit what it tells us about the most premature babies.
| Evidence | What it suggests | Important limit |
|---|---|---|
| Skin condition and water loss | Several trials report favourable results | Small studies with different neonatal populations |
| Serious infection | Some pooled findings are encouraging | Certainty is limited; direct trials are not uniformly positive |
| An unexplained baby rash | These trials do not establish treatment | Diagnosis and age-appropriate care remain necessary |
Infection prevention is still a separate question
A 2019 review of seven coconut-oil trials reported fewer hospital-acquired bloodstream infections in a pooled analysis of two studies. The review graded the evidence as low to moderate depending on the outcome and called for larger trials, particularly in very premature babies.
The 2021 Cochrane review of topical emollients assessed a wider range of products. Plant and vegetable oils may reduce invasive infection, but the certainty was low and mortality showed little or no difference. Results across several oils cannot all be attributed to coconut oil.
A 2026 trial protocol describes a much larger study of coconut oil and late-onset sepsis in babies born before 28 weeks. A protocol explains the planned investigation; it is not a completed positive result. The question remains important precisely because skin improvement does not automatically prove infection prevention.
Why adult dry-skin and childhood eczema studies are different
A controlled trial in mild to moderate dry skin compared virgin coconut oil with mineral oil as a moisturiser. It supports considering coconut oil within moisturising research, but it cannot decide neonatal skin care.
The childhood eczema trial also involved a defined condition and a different age group. Our coconut oil and eczema review examines those results separately. Neither study proves a remedy for nappy rash, infection, allergy or every patch of redness on a newborn.
What this means for parents
For a premature baby, ask the neonatal team which product, if any, belongs in the care plan. They can take account of gestational age, skin integrity, lines and dressings, and the unit’s infection-control procedures. Do not replace prescribed care with a kitchen product or add essential oils to coconut oil.
For routine bathing, NHS guidance allows just water or a cleanser suitable for babies and says to check that any oils or lotions are suitable for babies. A study in a neonatal unit does not mean every healthy newborn needs an oil routine. Seek advice from your midwife or health visitor about a rash or persistent skin problem.
The absence of reported irritation in a small trial cannot guarantee that every product suits every baby. Stop a new topical product if the skin worsens and seek professional advice. The studies also do not support putting oil into a baby’s mouth or using it as an infection treatment.
Our assessment
Finding: promising benefit for skin condition in neonatal care. Evidence strength: limited human evidence. Coconut oil has a real clinical research base. Its useful role is narrower than claims that it cures baby rashes or reliably prevents serious infection.
How this review was researched
Research checked on 14 September 2026. We searched PubMed for the named preparation and outcome, read the retrieved study abstracts and relevant reviews, and checked the linked health guidance. This is an editorial review, not an exhaustive systematic review. We identify studies of mixtures, other preparations and different patient groups rather than treating them as interchangeable evidence.
Related reading
- Coconut oil profile
- Coconut oil and eczema trials
- Rashes and essential-oil claims
- Essential oil safety
References
- Topical Oil Application and Trans-Epidermal Water Loss in Preterm Very Low Birth Weight Infants-A Randomized Trial.
- Topical Coconut Oil in Very Preterm Infants: An Open-Label Randomised Controlled Trial.
- Comparison of Coconut and Sunflower Seed Oils in Improving the Skin Integrity and Weight Gain of Infants in the Neonatal ICU.
- Topical application of coconut oil to the skin of preterm infants: a systematic review.
- Topical emollient for preventing infection in preterm infants.
- Can topical coconut oil reduce late-onset sepsis in extremely preterm infants? A pragmatic cluster-randomised controlled trial protocol.
- A randomized double-blind controlled trial comparing extra virgin coconut oil with mineral oil as a moisturizer for mild to moderate xerosis.
- The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial.
- NHS: Washing and bathing your baby